The technology behind the weekly pill is as much mechanical as it is pharmaceutical. Encased in a standard-size capsule is a ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common side effect of antipsychotic drugs.

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...

A pill taken just once a week, gradually releasing medicine from within the stomach, can greatly simplify the drug schedule ...

DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine receptors, so Cobenfy's action on cholinergic receptors offers a brand new way to treat ...

In a review study, researchers reported that omega-3 supplements may lessen the severity of schizophrenia symptoms in teens and young adults, especially those with low levels of omega-3s.

After decades of antipsychotic drugs, a new FDA-approved treatment for schizophrenia targets a different brain system—with ...